Social inequalities and correlates of psychotropic drug use among young adults: a population-based questionnaire study.

International Journal for Equity in Health
Nearkasen ChauLorhandicap Group

Abstract

Use of psychotropic drugs is widespread in Europe, and is markedly more common in France than elsewhere. Young adults often fare less well than adolescents on health indicators (injury, homicide, and substance use). This population-based study assessed disparities in psychotropic drug use among people aged 18-29 from different socio-occupational groups and determined whether they were mediated by educational level, health status, income, health-related behaviours, family support, personality traits, or disability. A total of 1,257 people aged 18-29, randomly selected in north-eastern France completed a post-mailed questionnaire covering sex, date of birth, height, weight, educational level, occupation, smoking habit, alcohol abuse, income, health-status, diseases, reported disabilities, self-reported personality traits, family support, and frequent psychotropic medication for tiredness, nervousness/anxiety or insomnia. The data were analyzed using the adjusted odds ratios (ORa) computed with logistic models. Use of psychotropic drugs was common (33.2%). Compared with upper/intermediate professionals, markedly high odds ratios adjusted for sex were found for manual workers (2.57, 95% CI 1.02-6.44), employees (2.58, 1.11-5.98), f...Continue Reading

References

Sep 1, 1994·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·S LedouxR Manfredi
Nov 22, 1997·Journal of Clinical Epidemiology·J F Etter, T V Perneger
May 26, 1999·Occupational and Environmental Medicine·K FredrikssonA Kilbom
Nov 18, 2000·Journal of the American Geriatrics Society·C L TurveyR Herzog
Sep 13, 2001·Journal of Epidemiology and Community Health·N Krieger
Jan 23, 2002·Journal of Occupational and Environmental Medicine·R Jeffrey LewisElizabeth G Lawhorn
Mar 23, 2002·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Maria Stella T GironJohan Fastbom
May 1, 2002·International Archives of Occupational and Environmental Health·U BültmannS V Kasl
Jun 19, 2002·Journal of Psychosomatic Research·Ute BültmannPiet A van den Brandt
Aug 15, 2002·Journal of Epidemiology and Community Health·I KawachiN Almeida-Filho
Jun 5, 2003·Occupational and Environmental Medicine·N JanssenC A P Schröer
Dec 17, 2003·Journal of Occupational Health·Ashis BhattacherjeeUNKNOWN Lorhandicap Group
Apr 28, 2004·Social Science & Medicine·Lucía ArtazcozIzabella Rohlfs
May 7, 2004·Acta Psychiatrica Scandinavica. Supplementum·J AlonsoUNKNOWN ESEMeD/MHEDEA 2000 Investigators, European Study of the Epidemiology of Mental Disorders (ESEMeD) Project
May 7, 2004·Acta Psychiatrica Scandinavica. Supplementum·J AlonsoUNKNOWN ESEMeD/MHEDEA 2000 Investigators, European Study of the Epidemiology of Mental Disorders (ESEMeD) Project
May 28, 2004·The Journal of Clinical Psychiatry·Susan L McElroyCharles B Nemeroff
Jul 6, 2004·Epidemiologic Reviews·Sandro GaleaDavid Vlahov
Sep 24, 2004·Pharmacoepidemiology and Drug Safety·T B Ngoundo-MbongueM Lapeyre-Mestre
Oct 16, 2004·Journal of Clinical Pharmacy and Therapeutics·M BaumannF Alla
Feb 3, 2005·Nature Reviews. Drug Discovery·Julio Licinio, Ma-Li Wong
Mar 5, 2005·Journal of Psychosocial Nursing and Mental Health Services·Suwanee Keawkingkeo
Jun 17, 2005·BMC Public Health·Isabelle GodinJohannes Siegrist
Sep 27, 2005·Journal of the American Academy of Nurse Practitioners·Carolyn T MartinErika Sivarajan Froelicher
Nov 5, 2005·Scandinavian Journal of Public Health·Jenny RundbergAgneta Ojehagen
Dec 7, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Macey L MurrayIan C K Wong
Dec 24, 2005·Neuroepidemiology·Gérome C GauchardUNKNOWN Lorhandicap group
Jan 4, 2006·Archives of Pediatrics & Adolescent Medicine·Kathleen Mullan HarrisJ Richard Udry
Jan 26, 2006·Revue D'épidémiologie Et De Santé Publique·N ChauUNKNOWN GROUPE LORHANDICAP
Feb 16, 2006·Social Psychiatry and Psychiatric Epidemiology·Olayinka O OmigbodunOladopo Olayemi
Jun 13, 2006·Journal of Affective Disorders·Bernice AndrewsJohn Wilding
Aug 22, 2006·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·M Jane ParkCharles E Irwin
Sep 16, 2006·Journal of Epidemiology and Community Health·Enrique Regidor
May 8, 2007·European Journal of Epidemiology·Nearkasen ChauMarie Choquet
Aug 19, 2007·International Archives of Occupational and Environmental Health·N ChauUNKNOWN Lorhandicap Group

❮ Previous
Next ❯

Citations

Apr 16, 2011·European Journal of Clinical Pharmacology·Olivia Boeuf-CazouMaryse Lapeyre-Mestre
Jul 1, 2011·Addiction·Malcolm Lader
Aug 1, 2015·Journal of Pharmacy & Bioallied Sciences·Che Fadhilah Bt MamatMohammad Jamshed Siddiqui
Oct 21, 2011·Revista da Associação Médica Brasileira·Lenka KračmarováIolanda Grappasonni
Jan 17, 2009·Social Psychiatry and Psychiatric Epidemiology·Patrick Peretti-WatelUNKNOWN Lorhandicap Group
Mar 1, 2014·Research Synthesis Methods·Alison O'Mara-EvesJames Thomas
Oct 10, 2015·International Journal for Equity in Health·Vivian WelchUNKNOWN PRISMA-Equity Bellagio group
Apr 20, 2017·Health Research Policy and Systems·Beverly D BradleyYu-Ling Cheng
Jul 10, 2018·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Sarah NanningaGabriele Bolte
May 10, 2019·Human Vaccines & Immunotherapeutics·Helvinder Kaur Balbir SinghMohammed Tahir Ansari

❮ Previous
Next ❯

Software Mentioned

ESEMeD

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.